These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 18912785)
21. [COMPARISON BETWEEN ELIMINATION OF BROMOSULFONPHTHALEIN AND ANATOMIC-HISTOLOGIC ALTERATIONS IN VARIOUS LIVER DISEASES]. MINERVA V; GRIMALDI N; GILLARDI U; BONOMO L Policlinico Med; 1963 Oct; 70():292-306. PubMed ID: 14098540 [No Abstract] [Full Text] [Related]
22. Results of hepatic tests in chronic hepatitis without jaundice; correlation with the clinical course and liver biopsy findings. NEEFE JR Gastroenterology; 1946 Jul; 7():1-19. PubMed ID: 20994233 [No Abstract] [Full Text] [Related]
23. [ENDOCRINE SIGNS AND SWELLING OF THE PAROTID GLANDS: CLINICAL SIGNS OF HEPATIC FUNCTION CHANGES IN LIVER DISEASES]. PERISIC V; GLIDZIC L; KANGRGA R; PASTRAKULJIC N Rev Int Hepatol; 1964; 14():577-86. PubMed ID: 14248808 [No Abstract] [Full Text] [Related]
24. [USE OF VITAMIN B 12 LABELED WITH CO 58 IN THE DIAGNOSIS OF PARENCHYMAL LIVER DISEASES]. BORON P; BORUCKI Z; BULHAK W; TREMBACZOWSKI E Pol Arch Med Wewn; 1964; 34():405-12. PubMed ID: 14251039 [No Abstract] [Full Text] [Related]
25. [Oral galactose tolerance test in liver diseases. Studies on technics and on the evaluation of results]. Hennecke A; König KJ; Südhof H Dtsch Med Wochenschr; 1972 Jan; 97(4):109-14 passim. PubMed ID: 5008209 [No Abstract] [Full Text] [Related]
26. [RADIOIODINE ROSE BENGAL FUNCTION TEST AND PERMEABILITY OF THE BILE DUCTS]. DESGREZ A; MANAMBELONA J; KELLERSHOHN C; CAROLI J; PAPANICOLAOU N; BLANCHON P; VANQUAETHEM M Pathol Biol; 1964; 12():711-7. PubMed ID: 14187719 [No Abstract] [Full Text] [Related]
27. [THE SIGNIFICANCE OF THE RELATION BETWEEN THE QUANTITY AND SPECIFIC WEIGHT OF URINE EXCRETED AFTER THE WOLLHEIM WATER TOLERANCE TEST IN LIVER DISEASES]. DELUTTEROTTI A; MAINIERI L; CIPOLLI PL Gazz Int Med Chir; 1963 Oct; 67():1972-81. PubMed ID: 14095272 [No Abstract] [Full Text] [Related]
28. An assessment of 5'-nucleotidase as a liver-function test. Hill PG; Sammons HG Q J Med; 1967 Oct; 36(144):457-68. PubMed ID: 6077226 [No Abstract] [Full Text] [Related]
29. [DETERMINATION OF THE FUNCTIONAL STATE OF THE LIVER IN DIFFERENT DISEASES WITH I-131-LABELLED ROSE BENGAL]. STARTSEVA EK Med Radiol (Mosk); 1963 Aug; 8():31-4. PubMed ID: 14086939 [No Abstract] [Full Text] [Related]
30. [CLINICAL EXPERIENCES WITH A SIMPLE PROGRAM FOR LABORATORY TESTS IN THE DIFFERENTIAL DIAGNOSIS OF LIVER DISEASES]. TEICHMANN W Z Gesamte Inn Med; 1964 Sep; 19():714-8. PubMed ID: 14236506 [No Abstract] [Full Text] [Related]
31. Indocyanine green clearance--a liver function test. Brügmann E; Töwe J Mater Med Pol; 1974; 6(2):123-6. PubMed ID: 4431244 [No Abstract] [Full Text] [Related]
32. [CLINICAL RESEARCH ON PYRUVIC ACID METABOLISM IN LIVER DISEASES. II. EFFECTS OF DIFFERENT DRUGS ON THE PYRUVIC ACID BLOOD LEVEL IN LIVER DISEASES]. KONO H Acta Med Okayama (1952); 1964 Apr; 18():93-110. PubMed ID: 14204463 [No Abstract] [Full Text] [Related]
33. [Studies on blood alkaline phosphatase and visceral alkaline phosphatase in liver disorders. II. Visceral alkaline phosphatase test in young rabbits during experimental liver disorders]. ONODERA H Paediatr Jpn; 1963; 67():199-206. PubMed ID: 13940168 [No Abstract] [Full Text] [Related]
34. [CLINICAL STUDIES ON THE INTERMEDIARY METABOLISM OF TYROSINE. 1. URINARY EXCRETION OF INTERMEDIARY METABOLITES OF TYROSINE IN HEALTHY INDIVIDUALS AND PATIENTS WITH LIVER DISORDERS]. AKISAWA J Naika Hokan; 1964 Mar; 11():85-95. PubMed ID: 14163645 [No Abstract] [Full Text] [Related]
35. [Thymol turbidity test in liver diseases]. Ozkaraoğlu S; Akşehirli M Turk Hij Tecr Biyol Derg (1961); 1973; 33(2-3):139-53. PubMed ID: 4805458 [No Abstract] [Full Text] [Related]
36. [STUDY OF THE FUNCTIONAL STATE OF THE LIVER WITH I-131-LABELLED ROSE BENGAL]. MOSHNIAGA TV Med Radiol (Mosk); 1963 Aug; 8():22-5. PubMed ID: 14086937 [No Abstract] [Full Text] [Related]
37. [Behavior of the iron turbidity test T66 compared with other liver function tests]. Jóźkiewicz S; Szymoński K; Stanosek J Wien Klin Wochenschr; 1969 Sep; 81(39):684-7. PubMed ID: 5344301 [No Abstract] [Full Text] [Related]
38. [MEDICAL EVALUATION OF PATIENTS WITH CHRONIC LIVER DISEASE]. BRUEHL W Munch Med Wochenschr; 1964 May; 106():885-91. PubMed ID: 14233339 [No Abstract] [Full Text] [Related]
39. [CLINICAL STUDY ABOUT THE TREATMENT OF HEPATOPATHIES WITH HEPATIC NUCLEOPEPTIDES]. URIASRODRIGUEZ R Rev Clin Esp; 1964 Feb; 92():177-80. PubMed ID: 14151559 [No Abstract] [Full Text] [Related]
40. [BSP--its values in various liver diseases and the function test by 121-I-BSP]. Ito K; Nakagawa J; Minakuchi C; Tamai Y; Nakano H Nihon Rinsho; 1971 Jan; 29():Suppl:341-50. PubMed ID: 4928278 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]